Contact ABPCO Tel: +44 (0)1386 858 886
EICC partners with Edinburgh BioQuarter to source  header internal EICC partners with Edinburgh BioQuarter to source  header internal


EICC partners with Edinburgh BioQuarter to source  header internal
October 7th 2019

EICC partners with Edinburgh BioQuarter to source increased industry opportunities for the city and Scotland

  image by

the Edinburgh International Conference Centre (EICC) and Edinburgh BioQuarter have established a partnership aimed at bringing more UK and global medicine and life sciences conferences to Edinburgh while helping to build Edinburgh BioQuarter’s pipeline of innovative companies and world-leading expertise. 

The EICC is internationally-renowned for hosting some of the world’s most significant life sciences industry conferences, while Edinburgh BioQuarter has built a reputation as a leading destination for healthcare delivery, groundbreaking medical research and life sciences innovation and entrepreneurship.

With a shared passion for raising the awareness of, and celebrating, opportunities within Scottish Life Sciences, the EICC and Edinburgh BioQuarter will jointly host EICC Live ‘The Future of Healthcare’ event, which is set to feature prominent players from Scotland’s life sciences and innovation sectors - with Jamie Coleman, Founder and Chair of CodeBase and Co-Founder and COO of immuno oncology drug discovery company UltraHuman, University of Edinburgh postdoctoral research scientist Dr Catherine Stables and Edinburgh Medical School’s Chair of Molecular Imaging and Healthcare Technology, Professor Kev Dhaliwal lined up as keynote speakers.

Marshall Dallas, Chief Executive of the EICC said: “Building on Scotland’s existing world-class reputation in medicine and life sciences, through the partnership we are aiming to attract more industry companies and associations to the city.  Our mission statement is ‘to create an environment which inspires ideas that change the world’ applies to many of the life sciences conferences that we hold here every year, and we know there is massive shared potential to bring even more of these events to Edinburgh.  Through our new partnership, and public events such as the EICC Live BioQuarter talk, we want to collaborate with partners across the country so that the whole nation benefits from increased life sciences business opportunities.”

Anna Stamp, Interim Programme Director of Edinburgh BioQuarter said: “We are looking forward to working with the EICC, an organisation which shares a similar vision to BioQuarter – which is to inspire innovative ideas and to revolutionise healthcare. Our partnership will bring a host of benefits to the resident companies based in NINE, our Life Sciences Innovation Centre and the many budding entrepreneurs and innovators working at the Royal Infirmary of Edinburgh and the University of Edinburgh’s world-class research institutes based across BioQuarter. Scotland punches above its weight in life sciences and healthcare innovation and through this partnership we can showcase these opportunities, while supporting the EICC to continue to deliver a host of leading conferences and events in these sectors.”

Adam Christie, CEO of CALCIVIS said: “CALCIVIS began operations in 2012 based in the Edinburgh BioQuarter and has grown from a small team of three to over a dozen employees.  We are excited about the new partnership between Edinburgh BioQuarter and the EICC, and look forward to the opportunities it will bring for the resident companies at BioQuarter to partner with EICC. We really see the benefits of networking and events, especially in terms of business development, and by bringing people together at major conferences in Edinburgh can have a truly positive impact on companies like Calcivis.”

About EICC Live: ‘The Future of Healthcare’

Informed by a rich history of medical breakthroughs, at Edinburgh BioQuarter great ideas are revolutionising health and wellbeing, which lead to improved treatments and better patient care. On a daily basis, clinical-academics meet life sciences entrepreneurs, and health data analysts link with NHS clinicians.

Health and life sciences entrepreneurship is alive and kicking at Edinburgh BioQuarter, and across Scotland, however ensuring the adoption and spread of innovation is a major challenge for the NHS. Such innovation comes at a cost during a time of pressure and competing demands on the healthcare system.

So, just how important is innovation to the NHS? Hear from a panel of experts who will share their amazing stories of medical innovation; while assessing the challenges, pitfalls and opportunities for the NHS as we head into a new decade of discovery.

About EICC

Opened in 1995, the remit of the Edinburgh International Conference Centre (EICC) is to drive economic impact to the city and to date has helped around £600 million to the local economy while hosting over one million delegates and 3,000 events. The EICC is owned by the City of Edinburgh Council and operates at arm’s length as an independent commercial venture. Edinburgh is the highest ranked UK conference destination outside London according to leading global industry body, the International Congress and Convention Association (ICCA).

About Edinburgh BioQuarter

Edinburgh BioQuarter is supported by four partners – the City of Edinburgh Council, NHS Lothian, Scottish Enterprise and the University of Edinburgh – each aligned to deliver experience, expertise and a dedication to BioQuarter’s success. The 100 acre BioQuarter campus - located 3 miles from the city centre of Edinburgh – is set to grow significantly over the next 10 years and beyond into the largest single-site development in Scotland for health and life sciences innovation. Across a campus built for collaboration, 7,500 people – from academics to entrepreneurs, researchers to frontline health professionals – are advancing opportunities for innovation, ultimately leading to improved patient care and revolutionary new treatments.                                                      


CALCIVIS is an innovative medical devices company focused on revolutionising the management of dental caries or ‘tooth decay’. The Calcivis Imaging System is in the latter stages of the FDA approval process and we intend to launch the product in the US market in 2020.


Copyright 2019 ABPCO. All Rights Reserved. Privacy and Cookies Terms and Conditions
VAT Reg No. 75 385 8001 England Reg No. 2111650

Our website uses cookies which are small files of letters and numbers that we put on your computer. These cookies allow us to distinguish you from other users of our website, which helps us to provide you with a good experience when you browse our website and also helps us to improve our website. Read more about the cookies we use by clicking here. By clicking CONTINUE you agree to cookies being used in accordance with our Cookie Policy. If you don't agree you can disable cookies - see the Cookie Policy for more details.